Digital and Pharma 4.0
Latest content
CPHI Milan 2026 preview: key themes and emerging trends
Explore the key themes, technologies and emerging trends shaping pharmaceutical development, manufacturing and commercialisation ahead of CPHI Milan 2026.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
CPHI Pharma Awards 2026 finalists announced
Winners of this year’s awards will be revealed during the opening of CPHI Milan 2026.
CHO perfusion model lifts yield by letting cellular waste build up
A hybrid model built into commercial software and running a self-driving bioreactor has found that unmeasured cellular waste, not the usual metabolites, throttles perfusion yields.
GSK to relocate UK R&D centre from Stevenage to Cambridge
Investment provides significant growth opportunity for UK’s life sciences sector and in shaping the country’s research and manufacturing footprint.
Building the foundation for the orchestrated lab of the future
As pharmaceutical laboratories face mounting pressure to accelerate timelines and manage growing data complexity, intelligent laboratory operations underpin the next generation of connected, autonomous lab environments.
Digital and Pharma 4.0
OpinionProcess Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.